Celsion Corporation [NASDAQ: CLSN] stock went on an upward path that rose over 47.89% on Monday, amounting to a one-week price increase of more than 14.69%. The company report on February 22, 2021 that Celsion Corporation Receives FDA Fast Track Designation for GEN-1 in Advanced Ovarian Cancer.
Celsion’s Commitment to Promoting Immune System Solutions to Fight Life-Threatening Diseases Granted an Accelerated Development Pathway.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Designation Provides Potential for an Expedited Regulatory Review.
Over the last 12 months, CLSN stock rose by 103.62%. The average equity rating for CLSN stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $176.30 million, with 34.11 million shares outstanding and 30.50 million shares in the current float. Compared to the average trading volume of 12.50M shares, CLSN stock reached a trading volume of 339228064 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Celsion Corporation [CLSN]:
Oppenheimer have made an estimate for Celsion Corporation shares, keeping their opinion on the stock as Perform, with their previous recommendation back on July 16, 2020. The new note on the price target was released on July 14, 2020, representing the official price target for Celsion Corporation stock. Previously, the target price had yet another raise to $7, while Maxim Group analysts kept a Buy rating on CLSN stock.
The Average True Range (ATR) for Celsion Corporation is set at 0.41, with the Price to Sales ratio for CLSN stock in the period of the last 12 months amounting to 352.60. The Price to Book ratio for the last quarter was 5.11.
CLSN Stock Performance Analysis:
Celsion Corporation [CLSN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 14.69. With this latest performance, CLSN shares gained by 61.49% in over the last four-week period, additionally plugging by 156.62% over the last 6 months – not to mention a rise of 103.62% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLSN stock in for the last two-week period is set at 69.99, with the RSI for the last a single of trading hit 71.80, and the three-weeks RSI is set at 68.95 for Celsion Corporation [CLSN]. The present Moving Average for the last 50 days of trading for this stock 1.25, while it was recorded at 2.20 for the last single week of trading, and 1.42 for the last 200 days.
Insight into Celsion Corporation Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Celsion Corporation [CLSN] shares currently have an operating margin of -4113.09. Celsion Corporation’s Net Margin is presently recorded at -3370.31.
Return on Total Capital for CLSN is now -73.22, given the latest momentum, and Return on Invested Capital for the company is -62.48. Return on Equity for this stock declined to -95.15, with Return on Assets sitting at -39.59. When it comes to the capital structure of this company, Celsion Corporation [CLSN] has a Total Debt to Total Equity ratio set at 77.86. Additionally, CLSN Total Debt to Total Capital is recorded at 43.77, with Total Debt to Total Assets ending up at 29.61. Long-Term Debt to Equity for the company is recorded at 62.55, with the Long-Term Debt to Total Capital now at 35.17.
Reflecting on the efficiency of the workforce at the company, Celsion Corporation [CLSN] managed to generate an average of -$581,087 per employee. Receivables Turnover for the company is 11.15 with a Total Asset Turnover recorded at a value of 0.01.Celsion Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.70 and a Current Ratio set at 3.70.
CLSN Stock EPS
With the latest financial reports released by the company, Celsion Corporation posted -0.1/share EPS, while the average EPS was predicted by analysts to be reported at -0.2/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 50.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLSN.
Celsion Corporation [CLSN] Insider Position Details
There are presently around $9 million, or 9.30% of CLSN stock, in the hands of institutional investors. The top three institutional holders of CLSN stocks are: VANGUARD GROUP INC with ownership of 1,265,670, which is approximately -0.323% of the company’s market cap and around 1.25% of the total institutional ownership; BLACKROCK INC., holding 709,245 shares of the stock with an approximate value of $1.99 million in CLSN stocks shares; and GSA CAPITAL PARTNERS LLP, currently with $0.75 million in CLSN stock with ownership of nearly 69.35% of the company’s market capitalization.
Positions in Celsion Corporation stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 12 institutional holders increased their position in Celsion Corporation [NASDAQ:CLSN] by around 494,185 shares. Additionally, 21 investors decreased positions by around 2,096,868 shares, while 13 investors held positions by with 775,492 shares. The mentioned changes placed institutional holdings at 3,366,545 shares, according to the latest SEC report filing. CLSN stock had 4 new institutional investments in for a total of 300,865 shares, while 14 institutional investors sold positions of 1,156,958 shares during the same period.